Acute Myocarditis: Clinical Trials

11 trials for Acute Myocarditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 5 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Recruiting 2, Not yet recruiting 1
Phase 22Completed 2
Not applicable1Completed 1
Phase 11Not yet recruiting 1

Follow Acute Myocarditis: new trials by email Literature Review of Acute Myocarditis trials Research Report on Acute Myocarditis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
64Cu-GRIP B in Patients With Acute Myocarditis
64Cu-GRIP B is a radiolabeled peptide tracer, a copper-64 isotope bound to a peptide designed to target extracellular Granzyme B - Acute Myocarditis
Phase 1Not yet recruitingJavid Moslehi, MD102027-01-012026-10-15
MyocarditIRM-Génétique - Genetic Sub-study of the French Cohort of Acute Myocarditis Cases Diagnosed by MRI
Acute Myocarditis
Active not recruitingFrench Cardiology Society6022025-07-152026-07-21
Corticoid Therapy in Acute Myocarditis
Intravenous administration of Methylprednisolone, Oral Prednisone, Perfusion of placebo - Acute Myocarditis
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris4202025-02-012024-07-29
The Role of Levosimendan as Inotropic Agent in Acute Aluminum Phosphide-induced Cardiotoxicity
levosemindan - Acute Myocarditis
Phase 3CompletedAin Shams University502024-12-202025-04-30
Colchicine Versus Placebo in Acute Myocarditis Patients
Colchicine Pill, Placebo - Acute Myocarditis
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris3002024-07-162026-02-25
MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)
Methylprednisolone 125 MG, IV saline solution 0.9% - Acute Myocarditis
Phase 3RecruitingUniversity Hospital, Antwerp1742024-05-242025-04-17
Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis
CardiolRx - Acute Myocarditis
Phase 2CompletedCardiol Therapeutics Inc.1092022-07-282026-09-30
Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases
Performing routine care (clinical and paraclinical tests), Examinations for the research: - Acute Myocarditis
CompletedUniversity Hospital, Toulouse7562020-04-152023-07-24
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
68Ga-DOTA-TOC PET/CT, Blood sample - Acute Myocarditis, Cardiac Sarcoidosis
Not applicableCompletedVastra Gotaland Region782020-01-202024-09-27
Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
ANAKINRA 100 mg/daily subcutaneously, Placebo - Acute Myocarditis
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris1202017-05-302024-03-06
German Centre for Cardiovascular Research Cardiomyopathy Register
Acute Myocarditis, Dilated Cardiomyopathies
UnknownHeidelberg University23002014-12-012016-03-25

Narrower conditions

Myocarditis (3)  ·  Cardiomyopathies (2)  ·  Cardiomyopathy, Dilated (2)  ·  Amyloidosis (1)  ·  COVID-19 (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cardiovascular Diseases (1)  ·  Disease (1)  ·  Heart Diseases (1)  ·  Inflammation (1)  ·  Ventricular Dysfunction, Left (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Heart Diseases (5)  ·  Cardiomyopathies (3)  ·  Cardiomegaly (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Laminopathies (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Heart Valve Diseases (1)

Interventions

Blood Specimen Collection (1)  ·  Cannabidiol (1)  ·  Colchicine (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Physical Examination (1)  ·  Prednisone (1)  ·  Sodium Chloride (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  Ain Shams University (1)  ·  Cardiol Therapeutics Inc. (1)  ·  French Cardiology Society (1)  ·  Heidelberg University (1)  ·  Javid Moslehi, MD (1)  ·  University Hospital, Antwerp (1)  ·  University Hospital, Toulouse (1)  ·  Vastra Gotaland Region (1)

Countries

France (5)  ·  United States (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Egypt (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Martinique (1)  ·  Mayotte (1)  ·  Reunion (1)  ·  Slovenia (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Caroline Van de Heyning (1)  ·  Christian L Polte, MD, PhD, MSc (1)  ·  Dennis McNamara, MD (1)  ·  Enrico Ammirati (1)  ·  Hugo A Katus, MD (1)  ·  Nicole Sturkenboom (1)  ·  Wolfgang Hoffmann, MD (1)

Results publications

PMID 37640625, PMID 39705605, PMID 42163845, PMID 42669063

NIH funding

2016 (1), 2019 (1)